125 related articles for article (PubMed ID: 10582334)
21. The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.
Backers K; Blero D; Paternotte N; Zhang J; Erneux C
Adv Enzyme Regul; 2003; 43():15-28. PubMed ID: 12791379
[No Abstract] [Full Text] [Related]
22. SHIP2 is recruited to the cell membrane upon macrophage colony-stimulating factor (M-CSF) stimulation and regulates M-CSF-induced signaling.
Wang Y; Keogh RJ; Hunter MG; Mitchell CA; Frey RS; Javaid K; Malik AB; Schurmans S; Tridandapani S; Marsh CB
J Immunol; 2004 Dec; 173(11):6820-30. PubMed ID: 15557176
[TBL] [Abstract][Full Text] [Related]
23. The SH2-containing inositol-5'-phosphatase enhances LFA-1-mediated cell adhesion and defines two signaling pathways for LFA-1 activation.
Rey-Ladino JA; Huber M; Liu L; Damen JE; Krystal G; Takei F
J Immunol; 1999 May; 162(10):5792-9. PubMed ID: 10229812
[TBL] [Abstract][Full Text] [Related]
24. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
[TBL] [Abstract][Full Text] [Related]
25. Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells.
Huber M; Helgason CD; Scheid MP; Duronio V; Humphries RK; Krystal G
EMBO J; 1998 Dec; 17(24):7311-9. PubMed ID: 9857188
[TBL] [Abstract][Full Text] [Related]
26. Impact of Src homology 2-containing inositol 5'-phosphatase 2 on the regulation of insulin signaling leading to protein synthesis in 3T3-L1 adipocytes cultured with excess amino acids.
Murakami S; Sasaoka T; Wada T; Fukui K; Nagira K; Ishihara H; Usui I; Kobayashi M
Endocrinology; 2004 Jul; 145(7):3215-23. PubMed ID: 15044364
[TBL] [Abstract][Full Text] [Related]
27. The role of SHIP in mast cell degranulation and IgE-induced mast cell survival.
Huber M; Kalesnikoff J; Reth M; Krystal G
Immunol Lett; 2002 Jun; 82(1-2):17-21. PubMed ID: 12008029
[TBL] [Abstract][Full Text] [Related]
28. SH2 domain-containing inositol polyphosphate 5'-phosphatase is the main mediator of the inhibitory action of the mast cell function-associated antigen.
Xu R; Abramson J; Fridkin M; Pecht I
J Immunol; 2001 Dec; 167(11):6394-402. PubMed ID: 11714805
[TBL] [Abstract][Full Text] [Related]
29. Molecular cloning and chromosomal localization in human and mouse of the SH2-containing inositol phosphatase, INPP5D (SHIP). Amgen EST Program.
Liu Q; Dumont DJ
Genomics; 1997 Jan; 39(1):109-12. PubMed ID: 9027494
[TBL] [Abstract][Full Text] [Related]
30. SHIP represses mast cell activation and reveals that IgE alone triggers signaling pathways which enhance normal mast cell survival.
Kalesnikoff J; Lam V; Krystal G
Mol Immunol; 2002 Sep; 38(16-18):1201-6. PubMed ID: 12217384
[TBL] [Abstract][Full Text] [Related]
31. Specific tyrosine phosphorylations mediate signal-dependent stimulation of SHIP2 inositol phosphatase activity, while the SH2 domain confers an inhibitory effect to maintain the basal activity.
Prasad NK; Werner ME; Decker SJ
Biochemistry; 2009 Jul; 48(27):6285-7. PubMed ID: 19518129
[TBL] [Abstract][Full Text] [Related]
32. Structure, function, and biology of SHIP proteins.
Rohrschneider LR; Fuller JF; Wolf I; Liu Y; Lucas DM
Genes Dev; 2000 Mar; 14(5):505-20. PubMed ID: 10716940
[No Abstract] [Full Text] [Related]
33. The SH2-containing inositol 5-phosphatase (SHIP)-1 is implicated in the control of cell-cell junction and induces dissociation and dispersion of MDCK cells.
Mancini A; Koch A; Wilms R; Tamura T
Oncogene; 2002 Feb; 21(10):1477-84. PubMed ID: 11896575
[TBL] [Abstract][Full Text] [Related]
34. The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity.
Vandeput F; Backers K; Villeret V; Pesesse X; Erneux C
Cell Signal; 2006 Dec; 18(12):2193-9. PubMed ID: 16824732
[TBL] [Abstract][Full Text] [Related]
35. Role of the Src homology 2 (SH2) domain and C-terminus tyrosine phosphorylation sites of SH2-containing inositol phosphatase (SHIP) in the regulation of insulin-induced mitogenesis.
Wada T; Sasaoka T; Ishiki M; Hori H; Haruta T; Ishihara H; Kobayashi M
Endocrinology; 1999 Oct; 140(10):4585-94. PubMed ID: 10499514
[TBL] [Abstract][Full Text] [Related]
36. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I
J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296
[TBL] [Abstract][Full Text] [Related]
37. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
[TBL] [Abstract][Full Text] [Related]
38. Src homology 2 domain-containing inositol polyphosphate phosphatase regulates NF-kappa B-mediated gene transcription by phagocytic Fc gamma Rs in human myeloid cells.
Tridandapani S; Wang Y; Marsh CB; Anderson CL
J Immunol; 2002 Oct; 169(8):4370-8. PubMed ID: 12370370
[TBL] [Abstract][Full Text] [Related]
39. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
[TBL] [Abstract][Full Text] [Related]
40. CD28 stimulates tyrosine phosphorylation, cellular redistribution and catalytic activity of the inositol lipid 5-phosphatase SHIP.
Edmunds C; Parry RV; Burgess SJ; Reaves B; Ward SG
Eur J Immunol; 1999 Nov; 29(11):3507-15. PubMed ID: 10556805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
